Stockreport

Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF 20mg) of its lead product candidate, buntanetap, for treating Parkinson's disease (PD). Per the company, treatment with the candidate demonstrated a safe and effective i [Read more]